NeuroPace (NPCE) Change in Accured Expenses (2020 - 2026)
NeuroPace's quarterly Change in Accured Expenses came in at -$4.0 million in Q1 2026, down 71.24% year-on-year from -$13.9 million in Q1 2025, and down 490.9% quarter-over-quarter from $1.0 million in Q4 2025.
NeuroPace has reported Change in Accured Expenses for 7 years, with the latest figure at -$4.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 71.24% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 1045.45% YoY), and the FY2025 full-year result was $3.6 million, up 355.17% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$4.0 million, down from $1.0 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $2.6 million in Q3 2025, with the low at -$4.0 million in Q1 2026.
- Average Change in Accured Expenses over 5 years is $112823.5, with a median of $454000.0 recorded in 2024.
- Year-over-year, Change in Accured Expenses soared 39975.0% in 2023 and plunged 366.43% in 2024.
- Tracing NPCE's Change in Accured Expenses over 5 years: stood at -$136000.0 in 2022, then jumped by 941.91% to $1.1 million in 2023, then plunged by 124.8% to -$284000.0 in 2024, then soared by 459.86% to $1.0 million in 2025, then tumbled by 490.9% to -$4.0 million in 2026.
- The last three Change in Accured Expenses figures came in at -$4.0 million (Q1 2026), $1.0 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | -4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.33 Mn |
| Dec 31, 2024 | -284,000.00 |
| Dec 31, 2024 | -284,000.00 |
| Sep 30, 2024 | 2.33 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 454,000.00 |
| Mar 31, 2024 | -3.89 Mn |
| Mar 31, 2024 | -3.89 Mn |
| Dec 31, 2023 | 1.15 Mn |
| Dec 31, 2023 | 1.15 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | -834,000.00 |
| Mar 31, 2023 | -834,000.00 |
| Dec 31, 2022 | -136,000.00 |
| Dec 31, 2022 | -136,000.00 |
| Sep 30, 2022 | 589,000.00 |
| Sep 30, 2022 | 589,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | -472,000.00 |
| Mar 31, 2022 | -472,000.00 |
| Dec 31, 2021 | -1.54 Mn |
| Dec 31, 2021 | -1.54 Mn |
| Sep 30, 2021 | 775,000.00 |
| Sep 30, 2021 | 775,000.00 |
| Jun 30, 2021 | 1.62 Mn |
| Jun 30, 2021 | 1.62 Mn |
| Mar 31, 2021 | -1.09 Mn |
| Mar 31, 2021 | -1.09 Mn |
| Dec 31, 2020 | -69,000.00 |
| Dec 31, 2020 | -69,000.00 |
| Sep 30, 2020 | 1.08 Mn |
| Sep 30, 2020 | 1.08 Mn |
| Jun 30, 2020 | 932,000.00 |
| Jun 30, 2020 | 932,000.00 |
| Mar 31, 2020 | -1.69 Mn |
| Mar 31, 2020 | -1.69 Mn |